TY - JOUR
T1 - Structural evolution of TIR-domain signalosomes
AU - Nimma, Surekha
AU - Gu, Weixi
AU - Maruta, Natsumi
AU - Li, Yan
AU - Pan, Mengqi
AU - Saikot, Forhad Karim
AU - Lim, Bryan Y.J.
AU - McGuinness, Helen Ying
AU - Zaoti, Zannati Ferdous
AU - Li, Sulin
AU - Desa, Sneha
AU - Manik, Mohammad Kawsar
AU - Nanson, Jeffrey D.
AU - Kobe, Bostjan
N1 - Funding Information:
This work was supported by funding from the National Health and Medical Research Council (NHMRC) (Project Grant 1160570 to BK) and the Australian Research Council (ARC) (Discovery Project DP190102526 and Laureate Fellowship FL180100109 to BK).
Funding Information:
Conflict of Interest: BK is a shareholder of Disarm Therapeutics, a wholly owned subsidiary of Eli Lilly & Company. BK is a consultant to Disarm Therapeutics. BK and WG receive research funding from Disarm Therapeutics.
Publisher Copyright:
Copyright © 2021 Nimma, Gu, Maruta, Li, Pan, Saikot, Lim, McGuinness, Zaoti, Li, Desa, Manik, Nanson and Kobe.
PY - 2021/11/17
Y1 - 2021/11/17
N2 - TIR (Toll/interleukin-1 receptor/resistance protein) domains are cytoplasmic domains widely found in animals and plants, where they are essential components of the innate immune system. A key feature of TIR-domain function in signaling is weak and transient self-association and association with other TIR domains. An additional new role of TIR domains as catalytic enzymes has been established with the recent discovery of NAD+-nucleosidase activity by several TIR domains, mostly involved in cell-death pathways. Although self-association of TIR domains is necessary in both cases, the functional specificity of TIR domains is related in part to the nature of the TIR : TIR interactions in the respective signalosomes. Here, we review the well-studied TIR domain-containing proteins involved in eukaryotic immunity, focusing on the structures, interactions and their corresponding functional roles. Structurally, the signalosomes fall into two separate groups, the scaffold and enzyme TIR-domain assemblies, both of which feature open-ended complexes with two strands of TIR domains, but differ in the orientation of the two strands. We compare and contrast how TIR domains assemble and signal through distinct scaffolding and enzymatic roles, ultimately leading to distinct cellular innate-immunity and cell-death outcomes.
AB - TIR (Toll/interleukin-1 receptor/resistance protein) domains are cytoplasmic domains widely found in animals and plants, where they are essential components of the innate immune system. A key feature of TIR-domain function in signaling is weak and transient self-association and association with other TIR domains. An additional new role of TIR domains as catalytic enzymes has been established with the recent discovery of NAD+-nucleosidase activity by several TIR domains, mostly involved in cell-death pathways. Although self-association of TIR domains is necessary in both cases, the functional specificity of TIR domains is related in part to the nature of the TIR : TIR interactions in the respective signalosomes. Here, we review the well-studied TIR domain-containing proteins involved in eukaryotic immunity, focusing on the structures, interactions and their corresponding functional roles. Structurally, the signalosomes fall into two separate groups, the scaffold and enzyme TIR-domain assemblies, both of which feature open-ended complexes with two strands of TIR domains, but differ in the orientation of the two strands. We compare and contrast how TIR domains assemble and signal through distinct scaffolding and enzymatic roles, ultimately leading to distinct cellular innate-immunity and cell-death outcomes.
KW - axon degeneration
KW - cell-death signaling
KW - innate immunity
KW - plant disease resistance
KW - protein structure
KW - protein-protein interactions
KW - signaling by cooperative assembly formation (SCAF)
KW - toll/interleukin-1 receptor/resistance protein
UR - http://www.scopus.com/inward/record.url?scp=85120427539&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85120427539&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2021.784484
DO - 10.3389/fimmu.2021.784484
M3 - Review article
C2 - 34868065
AN - SCOPUS:85120427539
SN - 1664-3224
VL - 12
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 784484
ER -